T2'-Magnetic resonance imaging (MRI) allows estimation of oxygen metabolism in normal appearing white and gray matter (NAWM and NAGM) and is sensitive to local iron deposition. We hypothesized that T2' imaging is feasible in routine use and reveals differences between MS patients and healthy subjects.
Methods
T2- and T2*-weighted images were acquired in 23 MS patients (Mean age: 36.8, range: 23–58 years) and 23 age-matched healthy subjects. Quantitative T2- and T2*-values were determined in six regions of interest (ROIs).
Results
The T2' values in thalamus and caudate nucleus were significantly lower in MS patients than in healthy subjects (139 ms vs 157 ms, P < 0.001 and 97 ms vs 115 ms, P < 0.01). The NAWM in the frontal lobe revealed significant higher T2' values than in healthy subjects (217 ms vs 170 ms, P < 0.001). The subcortical NAWM revealed significant lower T2' values than in healthy subjects (174 ms vs 187 ms, P < 0.028).
Conclusion
T2' values differed significantly between MS patients and healthy subjects. The reduced T2' values in the basal ganglia are presumably related to higher iron concentration whereas the increased T2' in frontal NAWM most probably reflects reduced tissue metabolism. T2' imaging is feasible for routine-use and promising for monitoring therapy effects.
1 Rovira A Alonso J Cucurella G . Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR images. AJNR Am J Neuroradiol1999; 20: 1939–1945.
2.
2 Miller DH . Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis. NeuroRx2004; 1: 284–294.
3.
3 Barkhof F van Walderveen M . Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance. Philos Trans R Soc Lond B Biol Sci1999; 354: 1675–1686.
4.
4 Jasperse B Minneboo A de Groot V . Determinants of cerebral atrophy rate at the time of diagnosis of multiple sclerosis. Arch Neurol2007; 64: 190–194.
5.
5 Chard DT Griffin CM McLean MA . Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain2002; 125(Pt 10): 2342–2352.
6.
6 Law M Saindane AM Ge Y . Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology2004; 231: 645–652.
7.
7 Inglese M Liu S Babb JS Mannon LJ Grossman RI Gonen O . Three-dimensional proton spectroscopy of deep gray matter nuclei in relapsing-remitting MS. Neurology2004; 63: 170–172.
8.
8 Inglese M Park SJ Johnson G . Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T. Arch Neurol2007; 64: 196–202.
9.
9 Zhang Y Zabad RK Wei X Metz LM Hill MD Mitchell JR . Deep grey matter “black T2” on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis. Mult Scler2007; 13: 880–883.
10.
10 Rashid W Parkes LM Ingle GT . Abnormalities of cerebral perfusion in multiple sclerosis. J Neurol Neurosurg Psychiatry2004; 75: 1288–1293.
11.
11 An H Lin W . Quantitative measurements of cerebral blood oxygen saturation using magnetic resonance imaging. J Cereb Blood Flow Metab2000; 20: 1225–1236.
12.
12 Geisler BS Brandhoff F Fiehler J . Blood-oxygen-level-dependent MRI allows metabolic description of tissue at risk in acute stroke patients. Stroke2006; 37: 1778–1784.
13.
13 Calamante F Lythgoe MF Pell GS . Early changes in water diffusion, perfusion, T1, and T2 during focal cerebral ischemia in the rat studied at 8.5 T. Magn Reson Med1999; 41: 479–485.
14.
14 Ding XQ Kucinski T Wittkugel O . Normal brain maturation characterized with age-related T2 relaxation times: an attempt to develop a quantitative imaging measure for clinical use. Invest Radiol2004; 39: 740–746.
15.
15 Brass SD Benedict RH Weinstock-Guttman B Munschauer F Bakshi R . Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis. Mult Scler2006; 12: 437–444.
16.
16 Roelcke U Kappos L Lechner-Scott J . Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study. Neurology1997; 48: 1566–1571.
17.
17 Derache N Marie RM Constans JM Defer GL . Reduced thalamic and cerebellar rest metabolism in relapsing-remitting multiple sclerosis, a positron emission tomography study: correlations to lesion load. J Neurol Sci2006; 245: 103–109.
18.
18 Stankiewicz J Panter SS Neema M Arora A Batt CE Bakshi R . Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics2007; 4: 371–386.
19.
19 Neema M Stankiewicz J Arora A . T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis. J Neuroimaging2007; 17(Suppl. 1): 16S–21S.
20.
20 Bakshi R Shaikh ZA Janardhan V . MRI T2 shortening (‘black T2’) in multiple sclerosis: frequency, location, and clinical correlation. Neuroreport2000; 11: 15–21.
21.
21 Bakshi R Dmochowski J Shaikh ZA Jacobs L . Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients. J Neurol Sci2001; 185: 19–26.
22.
22 Bakshi R Benedict RH Bermel RA . T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol2002; 59: 62–68.
23.
23 Ge Y Jensen JH Lu H . Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am J Neuroradiol2007; 28: 1639–1644.
24.
24 Bermel RA Puli SR Rudick RA . Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. Arch Neurol2005; 62: 1371–1376.
25.
25 Schenck JF Zimmerman EA . High-field magnetic resonance imaging of brain iron: birth of a biomarker? NMR Biomed2004; 17: 433–445.
26.
26 LeVine SM . Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res1997; 760: 298–303.
27.
27 Bakshi R Miletich RS Kinkel PR Emmet ML Kinkel WR . High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis. J Neuroimaging1998; 8: 228–234.
28.
28 Blinkenberg M Jensen CV Holm S Paulson OB Sorensen PS . A longitudinal study of cerebral glucose metabolism, MRI, and disability in patients with MS. Neurology1999; 53: 149–153.
29.
29 Siemonsen S; Finsterbusch J; Matschke J; Lorenzen A; Ding XQ; Fiehler J; . Age-Dependent Normal Values of T2* and T2' in Brain Parenchyma. AJNR Am J Neuroradiol 2008.
30.
30 Blinkenberg M Rune K Jensen CV . Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS. Neurology2000; 54: 558–564.
31.
31 Paulesu E Perani D Fazio F . Functional basis of memory impairment in multiple sclerosis: a[18F]FDG PET study. Neuroimage1996; 4: 87–96.
32.
32 Miller DH Johnson G Tofts PS MacManus D McDonald WI . Precise relaxation time measurements of normal-appearing white matter in inflammatory central nervous system disease. Magn Reson Med1989; 11: 331–336.
33.
33 Laule C Vavasour IM Moore GR . Water content and myelin water fraction in multiple sclerosis. A T2 relaxation study. J Neurol2004; 251: 284–293.
34.
34 Whittall KP MacKay AL Li DK Vavasour IM Jones CK Paty DW . Normal-appearing white matter in multiple sclerosis has heterogeneous, diffusely prolonged T(2). Magn Reson Med2002; 47: 403–408.
35.
35 Tozer DJ Davies GR Altmann DR Miller DH Tofts PS . Correlation of apparent myelin measures obtained in multiple sclerosis patients and controls from magnetization transfer and multicompartmental T2 analysis. Magn Reson Med2005; 53: 1415–1422.
36.
36 Pozzilli C Fieschi C Perani D . N, et al. Relationship between corpus callosum atrophy and cerebral metabolic asymmetries in multiple sclerosis. J Neurol Sci1992; 112: 51–57.
37.
37 Miller DH Grossman RI Reingold SC McFarland HF . The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain1998; 121(Pt 1): 3–24.
